169 related articles for article (PubMed ID: 29982350)
1. Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy.
Bremmer DN; Moffa MA; Ma K; Bean HR; Snatchko J; Trienski TL; Watson C; Walsh TL
Clin Infect Dis; 2019 Feb; 68(5):725-730. PubMed ID: 29982350
[TBL] [Abstract][Full Text] [Related]
2. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
5. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
Brownridge DJ; Zaidi STR
J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance.
Wang J; Cao B
Curr Opin Pulm Med; 2019 Mar; 25(2):158-164. PubMed ID: 30550505
[TBL] [Abstract][Full Text] [Related]
7. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
[No Abstract] [Full Text] [Related]
8. Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.
Kiser TH; Reynolds PM; Moss M; Burnham EL; Ho PM; Vandivier RW;
Pharmacotherapy; 2019 Mar; 39(3):242-252. PubMed ID: 30663791
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-guided initiation of antibiotics in AECOPD inpatients: study protocol for a multicenter randomised controlled trial.
Huang L; Wang J; Gu X; Sheng W; Wang Y; Cao B
BMJ Open; 2021 Aug; 11(8):e049515. PubMed ID: 34353802
[TBL] [Abstract][Full Text] [Related]
11. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K
Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
13. Introduction of a PCT-based algorithm to guide antibiotic prescription in COPD exacerbation.
Picart J; Moiton MP; Gaüzère BA; Gazaille V; Combes X; DiBernardo S
Med Mal Infect; 2016 Dec; 46(8):429-435. PubMed ID: 27609596
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
16. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
Pandey S; Garg R; Kant S; Verma A; Gaur P
Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin and antibiotics in moderate-severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use.
Chan HP; Lim TK
Curr Opin Pulm Med; 2019 Mar; 25(2):150-157. PubMed ID: 30418243
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Qian W; Huang GZ
Immunol Invest; 2016 Aug; 45(6):490-503. PubMed ID: 27224474
[TBL] [Abstract][Full Text] [Related]
20. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
